Origin Therapeutics Holdings (XCNQ:ORIG) Asset Turnover : 0.00 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Origin Therapeutics Holdings's Revenue for the three months ended in Jun. 2023 was C$0.00 Mil. Origin Therapeutics Holdings's Total Assets for the quarter that ended in Jun. 2023 was C$3.28 Mil. Therefore, Origin Therapeutics Holdings's Asset Turnover for the quarter that ended in Jun. 2023 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Origin Therapeutics Holdings's annualized ROE % for the quarter that ended in Jun. 2023 was -8.22%. It is also linked to ROA % through Du Pont Formula. Origin Therapeutics Holdings's annualized ROA % for the quarter that ended in Jun. 2023 was -7.80%.

Origin Therapeutics Holdings Asset Turnover Historical Data

The historical data trend for Origin Therapeutics Holdings's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Asset Turnover Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Asset Turnover

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Asset Turnover	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Origin Therapeutics Holdings's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Asset Turnover falls into.

Origin Therapeutics Holdings Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Origin Therapeutics Holdings's Asset Turnover for the fiscal year that ended in Sep. 2022 is calculated as

	Asset Turnover
=	Revenue	/	Average Total Assets
=	Revenue (A: Sep. 2022 )	/	( (Total Assets (A: Sep. 2021 )	+	Total Assets (A: Sep. 2022 ))	/ count )
=	0	/	( (7.059	+	5.588)	/ 2 )
=	0	/	6.3235
=	0.00

Origin Therapeutics Holdings's Asset Turnover for the quarter that ended in Jun. 2023 is calculated as

	Asset Turnover
=	Revenue	/	Average Total Assets
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	0	/	( (3.369	+	3.191)	/ 2 )
=	0	/	3.28
=	0.00

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Origin Therapeutics Holdings (XCNQ:ORIG) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Origin Therapeutics Holdings's annulized ROE % for the quarter that ended in Jun. 2023 is

	ROE %^**		(Q: Jun. 2023 )
=	Net Income	/	Total Stockholders Equity
=	-0.256	/	3.113
=	(Net Income / Revenue)	*	(Revenue / Total Assets)	*	(Total Assets / Total Stockholders Equity)
=	(-0.256 / 0)	*	(0 / 3.28)	*	(3.28/ 3.113)
=	Net Margin %	*	Asset Turnover	*	Equity Multiplier
=	%	*	0	*	1.0536
=	ROA %	*	Equity Multiplier
=	-7.80 %	*	1.0536
=	-8.22 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) net income data. The Revenue data used here is four times the quarterly (Jun. 2023) revenue data.

^** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Origin Therapeutics Holdings's annulized ROA % for the quarter that ended in Jun. 2023 is

	ROA %		(Q: Jun. 2023 )
=	Net Income	/	Total Assets
=	-0.256	/	3.28
=	(Net Income / Revenue)	*	(Revenue / Total Assets)
=	(-0.256 / 0)	*	(0 / 3.28)
=	Net Margin %	*	Asset Turnover
=	%	*	0
=	-7.80 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) net income data. The Revenue data used here is four times the quarterly (Jun. 2023) revenue data.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Origin Therapeutics Holdings Asset Turnover Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.